Review decisions
Showing 440 results of 1553 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683571472631
Product Type: Drug
Control Number: 266965
DIN(s): 02490315, 02490323, 02490331
Manufacturer: Bayer Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-08-12
Decision / Authorization Date: 2023-03-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683639670276
Product Type: Drug
Control Number: 261912
DIN(s): 02436523, 02436531, 02436558, 02536579
Manufacturer: Chiesi Canada Corp.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-01
Decision / Authorization Date: 2023-03-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01109
Product Type: Drug
Control Number: 267448
Manufacturer: Medicago Inc.
Submission Type: Supplement to a New Drug Submission (COVID-19)
Date Filed / Submission Date: 2022-08-30
Decision / Authorization Date: 2023-03-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1755266323193
Product Type: Drug
Control Number: 262121
Manufacturer: Pharma Stullin Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-03-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683131636864
Product Type: Drug
Control Number: 263702
DIN(s): 02434407, 02486733, 02486741, 02486768, 02486776
Manufacturer: Janssen Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-04-26
Decision / Authorization Date: 2023-03-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683132946136
Product Type: Drug
Control Number: 262810
DIN(s): 02468042
Manufacturer: Amicus Therapeutics UK Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2022-03-28
Decision / Authorization Date: 2023-03-23
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01101
Product Type: Drug
Control Number: 265517
DIN(s): 02536552, 02536560
Manufacturer: Hoffmann-La Roche Ltd.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-06-23
Decision / Authorization Date: 2023-03-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01099
Product Type: Drug
Control Number: 267362
DIN(s): 02536455
Manufacturer: Boehringer Ingelheim Canada Ltd./Ltée.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-08-26
Decision / Authorization Date: 2023-03-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1683129818889
Product Type: Drug
Control Number: 254426
DIN(s): 02534681, 02534703
Manufacturer: Apotex Inc
Submission Type: Abbreviated New Drug Submission
Date Filed / Submission Date: 2021-07-28
Decision / Authorization Date: 2023-02-06
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01098
Product Type: Drug
Control Number: 270857
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission - Confirmatory
Date Filed / Submission Date: 2022-12-20
Decision / Authorization Date: 2023-03-20